Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02955992
Other study ID # AOM15014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date January 2021

Study information

Verified date February 2021
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As ICU mortality is high, end-of-life is a subject of major concern for intensivists. With a mortality rate of 20%, end-of-life care has become a daily responsibility. Among those deaths, 60 to 80% follow a decision to withhold or withdraw treatment, situations where physicians, nurses and relatives must work together towards the most consensual decision. In this context, patients' relatives feel vulnerable and, in the months that follow the death, they are most likely to present symptoms that negatively affect their quality of life (anxiety, depression, PTSD, prolonged grief). Many studies have shown that communication with caregivers is one of the most highly valued aspects of care that impacts on family members' experience during the patient's stay and after the patient's death. Improving communication during the end-of-life process in the ICU context is a necessity that has been put forward in palliative care and family-centered care guidelines. This study aims to improve both communication skills and behaviour by giving precise recommendations to physicians (3 step strategy) in their direct contact with patients' relatives. A 3-step physician-driven support strategy is used, that consists in 3 meetings with the relative - one before, one during and one after the patient's death. The underlying hypothesis is that this strategy will improve communication in the end-of-life setting and thus should reduce post-ICU burden for family members, specifically the development of prolonged grief 6 months after the death.


Recruitment information / eligibility

Status Completed
Enrollment 900
Est. completion date January 2021
Est. primary completion date April 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Relatives of patients who died in the intensive care unit after a decision to withhold or withdraw treatment (adult ICUs only, ICU length of stay > 2 days). - Consent to participate in the study - Relative who was seen at least once by the physician before the patient's death Exclusion Criteria: - Relative that does not understand, read or speak French - Relative who refuses to participate

Study Design


Related Conditions & MeSH terms

  • Death
  • Patients Died in Intensive Care Unit (ICU)

Intervention

Behavioral:
Improving communication during the end-of-life process


Locations

Country Name City State
France Anesthésie Réanimation Beaujon Clichy
France Réanimation polyvalente Sud Francilien Evry
France Réanimation médicale Bicetre Le Kremlin-Bicêtre Val-de-marne
France Réanimation chirurgicale HEGP Paris
France Réanimation médicale Paris
France Réanimation médicale HEGP Paris
France Réanimation Médicale hôpital Cochin Paris
France Réanimation médicale Pitié Salpetriere Paris
France Réanimation médico chirurgicale Tenon Paris
France Réanimation polyvalente René Dubos Pontoise

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Questionnaire - lifestyle disruption Questionnaire developed by the Famiréa Group for relatives about lifestyle disruption 6 months post patient's death
Other Checklist Checklist for adherence of investigators to the intervention (intervention groups) 24 hours post patient's death
Primary PG-13 : Prolonged Grief Disorder-13 that measures symptoms of prolonged grief 6 months post patient's death
Secondary CAESAR scale that measured quality of dying and death 1 month post patient's death
Secondary Quality of dying and death (QODD-1) 1 month post patient's ddeath
Secondary Miss-21 - Rapport subscale that describes communication with physician 1 month post patient's death
Secondary Hospital Anxiety and Depression Scale (HADS) 1, 3 and 6 months post patient's death
Secondary Impact of Event Scale-Revised (IES-R) that measures post-traumatic stress symptoms 3 and 6 months post patient's death